![Global Diphtheria, Pertussis, and Tetanus (DTP) Vaccine Market to Reach $7.05 Billion by 2027: AMR | Medgadget Global Diphtheria, Pertussis, and Tetanus (DTP) Vaccine Market to Reach $7.05 Billion by 2027: AMR | Medgadget](https://www.medgadget.com/wp-content/uploads/2020/08/Diphtheria-Pertussis-and-Tetanus-DTP-Vaccine-Market.jpg)
Global Diphtheria, Pertussis, and Tetanus (DTP) Vaccine Market to Reach $7.05 Billion by 2027: AMR | Medgadget
![Vaccines | Free Full-Text | Evaluation of the Potency of the Pertussis Vaccine in Experimental Infection Model with Bordetella pertussis: Study of the Case of the Pertussis Vaccine Used in the Expanded Vaccines | Free Full-Text | Evaluation of the Potency of the Pertussis Vaccine in Experimental Infection Model with Bordetella pertussis: Study of the Case of the Pertussis Vaccine Used in the Expanded](https://www.mdpi.com/vaccines/vaccines-10-00906/article_deploy/html/images/vaccines-10-00906-g001.png)
Vaccines | Free Full-Text | Evaluation of the Potency of the Pertussis Vaccine in Experimental Infection Model with Bordetella pertussis: Study of the Case of the Pertussis Vaccine Used in the Expanded
![How tracking DTP vaccine dropout rates helps protect children from preventable diseases - UNICEF Data for Action Blog How tracking DTP vaccine dropout rates helps protect children from preventable diseases - UNICEF Data for Action Blog](https://data.unicef.org/data-for-action/wp-content/uploads/sites/6/2019/09/UN0201059-scaled.jpg)